Contact_Button   Home_Button



Novosense AB started in 2004, as a result of research collaboration between Acreo AB, Tilly Medical AB and Fredrik Sebelius. The company’s core business is in wireless sensor for medical or industrial applications. Novosense has a unique portfolio of production, sensor and radio-technology.
Patent has been granted for Novosense’s wireless ECG system in Sweden, China and USA. The PCT process is ongoing and patent applications are pending in several other countries.
The company is located in Lund, at the Ideon Science Park, which is a dynamic area for technology based companies, in close cooperation with Lund University, the largest university in Scandinavia.


Mission and Vision

The Company are developing wireless sensor systems for medical or industrial applications. Novosense are currently developing and lauching the following products:

  • A completely wireless ECG patient monitoring system for mainly use in cardiac care, intensive care and operating theatres.
  • A completely wireless vital sign monitoring system for home health care
  • Industrial wireless pressure and temperature sensors

Novosense also develops sensors as consultants for medical and industrial actors.

The vision is to be a market leader on wireless biometric sensors for the health care sector.

Novosense Markets

Medical Market
Novosense is focusing on the vital signs monitoring market in Europe and North America. The CardioSenseSystem® is developed for hospital environment, e.g. critical care units, cardiac care units and thoracic surgery Units. The home health care market is a rapidly growing market with increasing potential. Novosene’s vital sign monitoring system for home health care will be well adapted for the home health care market.


Industrial market
Novosense has developed a monitoring system for hydraulic pressure and temperature. The market is wood working and metal working machines with hydralic grips or any application that uses power transmission by hydralic pressure.